4726.TWO · MYCENAX
Taiwan · RS rating 15 · As of 2026-10-08
| Price | 23.80 TWD |
|---|---|
| 1-day change | +4.8% |
| RS rating (overall / 1M / 3M / 12M) | 15 / 52 / 35 / 9 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 31 / 12 / 44 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | +28.6% |
| Sales growth Q/Q | +3.2% |
| Distance from 52-week high | +37.3% |
| Market cap (USD) | $150.4M |